netFormulary NHS Crawley and NHS Horsham and Mid Sussex CCG NHS
Formulary  
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.04.01  Expand sub section  Drugs for urinary retention
07.04.01  Expand sub section  Alpha-blockers
Tamsulosin
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Green

Capsules MR
  • Indication - Benign Prostatic Hyperplasia 
  • Doxazosin
    View adult BNF View SPC online View childrens BNF  Track Changes
    Second Choice
    Green

    Immediate Release Tablets
  • Indication - Benign Prostatic Hyperplasia; Hypertension (section 2.5.4) 
  • Link  PCN 287-2017 Alpha Blockers for men with moderate to severe lower urinary tract symptoms.
       
    Alfuzosin Hydrochloride
    View adult BNF View SPC online View childrens BNF  Track Changes
    Third Choice
    Green

    Tablets M/R 


    • Indication - Benign Prostatic Hyperplasia

    BLUE Traffic Light

  • Indication for men with recurrent acute infection or acute or chronic urinary retention CPMAP Feb 2018

     
  • Link  PCN 287-2017 Alpha Blockers for men with moderate to severe lower urinary tract symptoms.
    Link  PCN 288-2017 Alfuzosin MR (modified release) for men with recurrent acute retention or acute chronic urinary retention (CPMAP agreed BLUE)
       
    Terazosin (Hytrin®)
    View adult BNF View SPC online View childrens BNF  Track Changes
    Formulary
    Green
    Tablets - Not 1st line


    • Indication - Benign Prostatic Hyperplasia, Hypertension
     
    Link  PCN 287-2017 Alpha Blockers for men with moderate to severe lower urinary tract symptoms.
       
    07.04.01  Expand sub section  Parasympathomimetics
     ....
     Non Formulary Items
    Alfuzosin  (Xatral®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Doxazosin MR

    View adult BNF View SPC online View childrens BNF Track Changes
    Non Formulary
    Black

    Tablets

    Link  PCN 307-2018 Prolonged-release Doxazosin (also known as Doxazosin Modified Release)
    Link  NHS England Guidance ’Items which should not routinely be prescribed in primary care
    Link  PCN 287-2017 Alpha Blockers for men with moderate to severe lower
     
    Dutasteride and Tamsulosin  (Combodart®)

    View adult BNF View SPC online View childrens BNF Track Changes
    Non Formulary
    Black

    • for the treatment of lower urinary tract symptoms in men
    Link  PCN 295-2017 Combodart® (dutasteride & tamsulosin) for the treatment of lower urinary tract symptoms in men
     
    Indoramin  (Doralese®)

    View adult BNF View SPC online View childrens BNF Track Changes
    Non Formulary
    Black
     
    Prazosin

    View adult BNF View SPC online View childrens BNF Track Changes
    Non Formulary
    Black
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Black

    Comment : Not to be routinely commissioned (prescribed) in any care setting (primary or secondary care). This may be due to a lack of good clinical evidence, cost effectiveness, concerns over safety or due to the availability of more suitable alternatives. As such, drugs classified as Black should be considered as non-formulary.   

    Red

    Initiation : Specialist only
    Repeat Prescribing : Specialist
    Monitoring : Specialist
    Comment : Prescribing must be in line with any specific treatment criteria outlined. In exceptional circumstances a GP may be asked to prescribe – the specialist must provide adequate information and support.   

    Amber

    Initiation : Specialist only
    Repeat Prescribing : Primary care OR specialist
    Monitoring : Primary care OR specialist
    Comment : Monitoring according to Effective Shared Care Agreement (ESCA) for stabilised patients only. GP agreement should be requested by specialist and confirmed/declined by GP on a patient-by-patient basis.   

    Blue

    Initiation/Recommendation : Specialist only
    Repeat Prescribing : Primary care
    Monitoring : Primary care
    Comment : Should be initiated or recommended by a specialist. Monitoring of either medicine or disease does not require specialist skills or equipment   

    Green

    Initiation : Primary care or specialist
    Repeat Prescribing : Primary care
    Monitoring : Primary care
    Comment : Suitable for non specialist initiation   

    OTC

    Patients should be advised to purchase if approriate.  

    netFormulary